290 related articles for article (PubMed ID: 33723501)
1. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.
Yan H; Sun J; Wang K; Wang H; Wu S; Bao L; He W; Wang D; Zhu A; Zhang T; Gao R; Dong B; Li J; Yang L; Zhong M; Lv Q; Qin F; Zhuang Z; Huang X; Yang X; Li Y; Che Y; Jiang J
Acta Pharm Sin B; 2021 Sep; 11(9):2850-2858. PubMed ID: 33723501
[TBL] [Abstract][Full Text] [Related]
2. Cytopathic Effect Assay and Plaque Assay to Evaluate
Hu Y; Ma C; Wang J
Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599
[TBL] [Abstract][Full Text] [Related]
3. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
4. Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed -1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element.
Li H; Li J; Li J; Li H; Wang X; Jiang J; Lei L; Sun H; Tang M; Dong B; He W; Si S; Hong B; Li Y; Song D; Peng Z; Che Y; Jiang JD
Acta Pharm Sin B; 2024 Jun; 14(6):2567-2580. PubMed ID: 38828157
[TBL] [Abstract][Full Text] [Related]
5. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
6. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.
Yang CW; Lee YZ; Hsu HY; Jan JT; Lin YL; Chang SY; Peng TT; Yang RB; Liang JJ; Liao CC; Chao TL; Pang YH; Kao HC; Huang WZ; Lin JH; Chang CP; Niu GH; Wu SH; Sytwu HK; Chen CT; Lee SJ
Front Pharmacol; 2020; 11():606097. PubMed ID: 33519469
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
9. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
Butot S; Baert L; Zuber S
Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
[TBL] [Abstract][Full Text] [Related]
12. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
[TBL] [Abstract][Full Text] [Related]
13.
Lang P; Geertsen SS; Lublin AL; Potter MC; Gladysheva T; Gregory JS; Rufi P
Biochem Biophys Rep; 2023 Mar; 33():101395. PubMed ID: 36437966
[TBL] [Abstract][Full Text] [Related]
14. Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity.
Guzmán-Martínez O; Guardado K; Varela-Cardoso M; Trujillo-Rivera A; Gómez-Ñañez I; Ortiz-León MC; Espinosa R; Ramos C; Pérez-Carreón JI; López-Guerrero DV; Sampieri CL; Alanís-García AB; Rojas-Durán F; Zenteno-Cuevas R; Gutiérrez M; Montero H
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501647
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
[TBL] [Abstract][Full Text] [Related]
16. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
17. Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
Li J; Wang Y; Solanki K; Atre R; Lavrijsen M; Pan Q; Baig MS; Li P
Antiviral Res; 2023 Mar; 211():105555. PubMed ID: 36791846
[TBL] [Abstract][Full Text] [Related]
18. Improved plaque assay for human coronaviruses 229E and OC43.
Bracci N; Pan HC; Lehman C; Kehn-Hall K; Lin SC
PeerJ; 2020; 8():e10639. PubMed ID: 33391888
[TBL] [Abstract][Full Text] [Related]
19. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro.
Jang M; Park R; Park YI; Cha YE; Yamamoto A; Lee JI; Park J
Biochem Biophys Res Commun; 2021 Apr; 547():23-28. PubMed ID: 33588235
[TBL] [Abstract][Full Text] [Related]
20. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
Hoffmann HH; Schneider WM; Sánchez-Rivera FJ; Luna JM; Ashbrook AW; Soto-Feliciano YM; Leal AA; Le Pen J; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM
bioRxiv; 2020 Sep; ():. PubMed ID: 32935098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
